Scarborough Advisors, LLC

Position in JNJ — Johnson & Johnson

CIK 1815355 ANNAPOLIS, MD

Position in JNJ

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$237,969

-$2,804 QoQ

Shares Held

937

-4.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

#4,372

of 4,664 holders

Holding Since

Jun 2023

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Scarborough Advisors, LLC holds $1,515,832 across 3 Drug Manufacturers - General names. JNJ ranks #3 (15.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	723	$867,187
2	ABBV	AbbVie Inc.	1,632	$410,676
3	JNJ	Johnson & Johnson This page	937	$237,969

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$237,969	937	-4.9%	Shares	Sole	2026-07-21
2026-03-31	$240,773	985	-33.3%	Shares	Sole	2026-05-07
2024-09-30	$239,362	1,477	+2.3%	Shares	Sole	2024-10-31
2023-12-31	$226,332	1,444	+0.2%	Shares	Sole	2024-02-29
2023-09-30	$224,435	1,441	+17.5%	Shares	Sole	2023-11-30
2023-06-30	$202,927	1,226	—	Shares	Sole	2023-09-07
No filing history on record for this holder in this stock.